《2009CCO/PET成像用于小细胞肺癌诊断》内容简介:
What benefit to clinical management does positron emission tomography (PET) or positronemission tomography/computed tomography (PET/CT) contribute to the diagnosis orstaging of small cell lung cancer (SCLC).
《2009CCO/PET成像用于小细胞肺癌诊断》内容预览:
What benefit to clinical management does PET or PET/CT contribute to the assessment oftreatment response for small cell lung cancer.
What benefit to clinical management does PET or PET/CT contribute when recurrence ofsmall cell lung cancer is suspected but not proven.
What benefit to clinical management does PET or PET/CT contribute to restaging at thetime of documented recurrence for small cell lung cancer.
What is the role of PET when a solitary metastasis is identified at the time of recurrenceand the metastectomy is being contemplated.
点击下载***:《2009CCO/PET成像用于小细胞肺癌诊断》
本共识意见(草案)依据我国胰腺囊性肿瘤的最近研究,并参考国际相关指南和研究...[详细]
在美国,结直肠癌发病率占所有癌症的第四位,而死亡率为第二位。2012年估计...[详细]